NCT07184047 2026-02-20
TOX-FRAIL
Ankara Etlik City Hospital
Completed
Clinical Trials
10 trialsNCT06792149 2025-01-24
Prediction of Drug Response in Gastric Cancer Based on 3D Bioprinting
Peking Union Medical College Hospital
Recruiting
NCT06369480 2024-04-17
Prognostic Factors for Survival in Patients With Cholangiocarcinoma
Rigshospitalet, Denmark
Recruiting
NCT06208436 2024-01-17
The Survival Outcome of Adjuvant Chemotherapy for Stage I Pancreatic Cancer
Tianjin Medical University Cancer Institute and Hospital
Unknown
NCT04755907 2022-07-19
3D Bioprinted Models for Predicting Chemotherapy Response in Colorectal Cancer With/Without Liver Metastases
Peking Union Medical College Hospital
Unknown
NCT04513457 2021-03-29
Chemotherapy for Resectable Colorectal Liver Metastases
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Completed
NCT04737551 2021-02-04
Adjuvant Chemoradiation Following Radical Resection of Pancreatic Ductal Adenocarcinoma, a Prospective Cohort Study
Shanghai Zhongshan Hospital
Unknown
NCT03899870 2019-04-02
Factors Predicting Recurrence in Rectal Cancer After Surgery
Université de Sousse
Completed
NCT00898846 2016-09-28
Identifying Prognostic Factors in Patients Receiving Tegafur-Uracil for Stage II Colon Cancer That Was Completely Removed By Surgery
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Completed
NCT00873600 2015-03-19
Outpatient Health Care Program for Older Patients Receiving Chemotherapy for Newly Diagnosed Breast Cancer or Colon Cancer
Case Comprehensive Cancer Center
Withdrawn